Skip to main content
TipRanks
Go Ultimate75% OFF

Cryo-Cell International (CCEL) Stock Price & Analysis

57 Followers

CCEL Stock Chart & Stats

$4.55-$0.30(-6.19%)
At close: 4:00 PM EST
$3.5$4$4.5$5Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$4.11 - $4.72
52-Week Range
$2.72 - $5.45
Previous Close
$4.85
Volume
N/A
Average Volume (3M)
12.24K
Market Cap
$36.69M
Enterprise Value
$38.46M
Total Cash (Recent Filing)
$4.23M
Total Debt (Recent Filing)
$577.20K
Price to Earnings (P/E)
―
Beta
0.13
Next Earnings
Feb 26, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Positive Cash Generation

Positive operating and free cash flow provides internally generated funding for ongoing operations and customer service commitments. Its resilience despite reported net losses is a meaningful business strength, although sustaining this cash conversion will remain important for rebuilding financial flexibility.

Strong Gross Margin

A gross margin near 77% indicates that the core service offering retains substantial economics after direct costs. This creates potential to support laboratory operations, customer acquisition, and investment in the platform, provided operating expenses can be managed well enough to restore consistent profitability.

Recurring Storage Revenue Model

The combination of upfront processing revenue and recurring long-term storage fees can create durable customer relationships and a growing installed base of stored units. Retention and new enrollments therefore have the potential to compound revenue visibility beyond one-time birth-related transactions.

Bears Say

Deeply Negative Equity

Deeply negative equity leaves the company with a strained capital structure and reduces financial flexibility even though total debt has declined from earlier periods. The deficit reflects accumulated balance-sheet pressure and must be rebuilt before the company can operate with a more durable financial cushion.

Inconsistent Profitability

Current net losses weaken the company’s ability to fund growth and repair its balance sheet through retained earnings. The history of profitability recovering and then deteriorating again also indicates inconsistent earnings quality, making durable margins and dependable long-term earnings power less established.

Stagnant Revenue Trend

Flat to declining revenue suggests that customer enrollment, pricing, retention, or related service growth is not currently expanding the business meaningfully. Without renewed top-line growth, the company has less operating leverage to absorb costs, improve earnings, and generate the resources needed to strengthen its finances.

Cryo-Cell International News

CCEL FAQ

What was Cryo-Cell International’s price range in the past 12 months?
Cryo-Cell International lowest stock price was $2.72 and its highest was $5.45 in the past 12 months.
What is Cryo-Cell International’s market cap?
Cryo-Cell International’s market cap is $36.69M.
When is Cryo-Cell International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cryo-Cell International’s earnings last quarter?
Cryo-Cell International released its earnings results on Oct 09, 2026. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.13.
Is Cryo-Cell International overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cryo-Cell International pay dividends?
Cryo-Cell International pays a quarterly dividend of $0.15 which represents an annual dividend yield of ―. See more information on Cryo-Cell International dividends here
What is Cryo-Cell International’s EPS estimate?
Cryo-Cell International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryo-Cell International have?
Cryo-Cell International has 8,062,650 shares outstanding.
What happened to Cryo-Cell International’s price movement after its last earnings report?
Cryo-Cell International reported an EPS of $0.16 in its last earnings report, beating expectations of $0.03. Following the earnings report the stock price went up 3.211%.
Which hedge fund is a major shareholder of Cryo-Cell International?
Hedge funds hold Cryo-Cell International shares: the largest hedge-fund position in Cryo-Cell International is 72,328,962 shares, and hedge funds decreased their holdings by 7.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology